ALLERGAN PLC

ALLERGAN PLC

Displaying 10 out of 8 results

  1. A trader works at the post that trades Parsley Energy Inc. and  Allergan Plc., on the floor of the

    Allergan promises independent board chair in next leadership change

    Allergan Plc plans to elect an independent board chairman, starting with the next leadership transition, the Botox maker said on Friday, as the ...
  2. FILE PHOTO: The Allergan logo is seen in this photo illustration

    Allergan's add-on treatment for depression fails late-stage studies

    Allergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage ...
  3. David Tepper, founder of Apploosa Management, speaks during the Sohn Investment Conference in New Y

    Appaloosa's Tepper says Allergan should consider selling itself

    Billionaire hedge fund manager David Tepper said on Tuesday Allergan Plc should consider selling itself if its management is unable to turn around ...
  4. FILE PHOTO - The Allergan logo is seen in this photo illustration in Singapore

    Appaloosa renews call to separate chairman, CEO roles at Allergan

    Hedge fund Appaloosa LP has urged Allergan Plc's board to separate the roles of chairman and chief executive officer, it said on Tuesday, a year ...
  5. The Allergan logo is seen in this photo illustration in Singapore

    Health Canada places restrictions on Allergan's fibroid treatment Esmya

    Canada's health regulator on Friday said it was restricting the use of Allergan Plc's uterine fibroid treatment Esmya after discovering a risk of ...
  6. The Allergan logo is seen in this photo illustration

    Allergan says revenue from aesthetics unit may double by 2025

    Allergan Plc said revenue from its medical aesthetics business could double by 2025, even as it faces increasing competition for its blockbuster ...
  7. The Allergan logo is seen in this photo illustration

    US court rejects Allergan bid to shield patents through tribe deal

    A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative ...
  8. The Allergan logo is seen in this photo illustration

    Allergan, Molecular Partners eye drug meets main goal in two studies

    Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage ...